Delivery Order SPE2DB20D2104-SPE2DB26FMBBM
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) on August 13, 2025, for Eliquis 5 mg tablets in a 60-count package. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $10,815.81 and is set to be completed by August 14, 2025. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 12, 2025, by the Defense Logistics Agency (DLA) for the supply of Eliquis 2.5 mg tablets in a 60-count package configuration. This firm fixed-price delivery order carries a ceiling value of $3,931.20 and is scheduled for completion by September 15, 2025. The award was made through open competition with no set-aside designation and represents a...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $18,978.90. This non-set-aside competitive award is scheduled for completion by August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $11,416.41. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a total value of $999,999,999.00 through December 2026. The work is to be performed at AmerisourceBergen's...
- AmerisourceBergen Drug Corp was awarded a delivery order on September 9, 2025, by the Defense Logistics Agency to supply 60 tablets of Eliquis 5 mg for $12,352.75, with final delivery required by September 10, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of the vendor's substantial pharmaceutical supply relationship with the federal government. The order was fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $14,034.53 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units. This non-set-aside contract is valued at $65,077.76 and represents a firm fixed-price delivery order with an ultimate completion date of July 23, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical supply arrangement. This delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 27, 2025, for the supply of Eliquis 5 mg tablets (60-count packaging) with a ceiling value of $1,768.36. This firm fixed price, competitively awarded delivery order represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with the federal government, with performance scheduled for...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Eliquis 5 mg tablets (60-count) with a ceiling value of $5,382.14. This is a firm fixed-price delivery order with an ultimate completion date of July 22, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,756.45 by the Defense Logistics Agency on September 4, 2025, for the supply of Eliquis 5 mg tablets (60-count units). The contract is classified as a non-set-aside award with firm fixed-price terms and an ultimate completion date of September 5, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB26FMBBMDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on October 28, 2025, for the supply of Eliquis 5 mg tablets (60-count packaging) with a ceiling value of $11,515.58. This competitively awarded, firm fixed-price delivery order is funded by the Defense Logistics Agency and is scheduled for completion by October 29, 2025. The contract carries no set-aside designation, reflecting the open competition process through which AmerisourceBergen was selected. This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive pharmaceutical support vehicle enables AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. The Eliquis order exemplifies the company's role as a critical federal vendor for pharmaceutical procurement, delivering brand-name medications essential to military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.5k | 10/28/25 |